Skip to main content
Clinical Trials/NCT03071549
NCT03071549CompletedPhase 3

Clinical and Dermoscopic Study Using a Combination of Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Mild to Moderate Acne , A Split Face, Double Blinded, Randomised Controlled Trial

Cairo University0 sites34 target enrollmentStarted: April 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
34
Primary Endpoint
Change in acne lesions count

Study Overview

Brief Summary

Acne patients were included in this randomized controlled trial. Each patient received four treatment sessions two weeks apart. 20% azelaic acid combined with 20% salicylic acid were applied to the one side of the face while 25% trichloroacetic acid was applied to the other side. Evaluation was done by counting number of non-inflammatory and inflammatory lesions before, after two and after four treatment sessions. The dermoscope was used in evaluating the degree of improvement of erythema.

Detailed Description

This study included 34 patients with mild and moderate acne vulgaris. The patients were recruited from the dermatology outpatient clinic of Kasr AlAiny hospital.

This study was approved by the Ethical committee of the Faculty of Medicine Cairo University and the Ethical committee of the Dermatology department Cairo University.

After signing an informed consent, patients were subjected to history taking, clinical examination and grading of their acne by global acne grading score, photography, dermoscopic examination and chemical peeling.

Photography:

Patient was photographed from front, lateral and side view before each session and two weeks after the 4th session. All photographs were taken using a digital camera (Nikon AW1, Indonesia) with identical lightening and patient positions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • any patients with active acne

Exclusion Criteria

  • History of oral herpes simplex virus.
  • History of keloid formation.
  • Associated autoimmune disease (e.g vitiligo, systemic lupus erythematosus).
  • History of past medications in the last six months.
  • Patient unable to perform necessary postoperative care

Arms & Interventions

combined azaleic and salicylic acids

Active Comparator

Combined azaleic acid 20% with salicylic acid 20% peel every 2 weeks for 4 sessions

Intervention: combined azaleic and salicylic acids (Drug)

Trichloroacetic acid peel

Active Comparator

Trichloroacetic acid 25% peel every 2 weeks for 4 sessions

Intervention: Trichloroacetic acid peel (Drug)

Outcomes

Primary Outcomes

Change in acne lesions count

Time Frame: 8 weeks

Change from baseline inflammatory and non-inflammatory lesions count at 2 months

Secondary Outcomes

  • change in acne erythema grading(2 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Rania Abdel hay

Associate professor of dermatology

Cairo University

Similar Trials

Combined Salicylic and Azaleic Acid Verus... | Clinical Trial